Study optimizes hydrogen yield in ethanol steam reforming, suggesting effective catalyst properties.
The need for a transition to a low-carbon economy has led to the growing demand for hydrogen as a clean energy source. Hence, ethanol steam reforming (ESR) is one of the promising technological pathways for hydrogen production. Ethanol, which is the major feedstock, can be obtained from abundant biomass. However, one of the major drawbacks is catalyst deactivation due to the high temperature requirement to start the reaction. This study therefore focused on employing a response surface approach to optimize the operating conditions (reaction temperature, steam-to-ethanol ratio and catalyst amount) of ethanol steam reforming over an Iridium-promoted Ni/MCM-41 catalyst. The Iridium-promoted Ni/MCM-41 catalyst was synthesized using the sequential wet impregnation method and characterized using field emission scanning electron microscopy (FESEM), energy dispersive X-ray spectroscopy (EDS), transmission electron microscopy (TEM), N2 physisorption analysis, and X-ray diffraction (XRD). A central composite experiment design (CCD) was employed to study the effect of the variables on the hydrogen production from the ESR. The catalytic efficacy was ascertained by evaluating the H2 yield under varied experimental conditions provided by the CCD. The characterization of the catalyst revealed well-dispersed Ir and Ni nanoparticles on a mesoporous MCM-41 support. Catalytic evaluations indicate that the H2 yield was most influenced by the reaction temperature (correlation coefficient of 0.68), followed by the catalyst amount (correlation coefficient of 0.34) and steam-to-ethanol ratio (correlation coefficient of 0.28). A maximum H2 yield of 5.82 mol/mol ethanol was obtained at 798.11 °C, a steam-to-ethanol ratio of 3.40, and 1.25 g of catalyst. These findings underscore the importance of Ir-promoted Ni/MCM-41 catalyst for efficient H2 production, highlighting the reaction temperature as a critical parameter for process optimization.
No takes yet. Share an insight, caveat, or question.
Ramesh Kanthasamy (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: